Tauns Laboratories Inc
TSE:197A

Watchlist Manager
Tauns Laboratories Inc Logo
Tauns Laboratories Inc
TSE:197A
Watchlist
Price: 534 JPY -0.19% Market Closed
Market Cap: ¥55.2B

Operating Margin

34.8%
Current
Declining
by 8.6%
vs 3-y average of 43.4%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
34.8%
=
Operating Income
¥5.1B
/
Revenue
¥14.6B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
34.8%
=
Operating Income
¥5.1B
/
Revenue
¥14.6B

Peer Comparison

Country Company Market Cap Operating
Margin
JP
Tauns Laboratories Inc
TSE:197A
55.1B JPY
Loading...
JP
Hoya Corp
TSE:7741
8.5T JPY
Loading...
CH
Alcon AG
SIX:ALC
31B CHF
Loading...
US
Medline Inc
NASDAQ:MDLN
36.2B USD
Loading...
DK
Coloplast A/S
CSE:COLO B
121.3B DKK
Loading...
US
Align Technology Inc
NASDAQ:ALGN
12B USD
Loading...
UK
ConvaTec Group PLC
LSE:CTEC
4.8B GBP
Loading...
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
43.8B CNY
Loading...
CA
Bausch + Lomb Corp
NYSE:BLCO
6B USD
Loading...
CH
Ypsomed Holding AG
SIX:YPSN
4.5B CHF
Loading...
KR
HLB Inc
KOSDAQ:028300
7.5T KRW
Loading...

Market Distribution

Higher than 95% of companies in Japan
Percentile
95th
Based on 6 730 companies
95th percentile
34.8%
Low
-125 500% — 4.2%
Typical Range
4.2% — 10.6%
High
10.6% — 9 743.7%
Distribution Statistics
Japan
Min -125 500%
30th Percentile 4.2%
Median 7%
70th Percentile 10.6%
Max 9 743.7%

Tauns Laboratories Inc
Glance View

Market Cap
55.2B JPY
Industry
Health Care

TAUNS Laboratories, Inc. develops and manufactures vitro diagnostic drugs & measuring instruments. The company is headquartered in Izunokuni-Shi, Shizuoka-Ken and currently employs 316 full-time employees. The company went IPO on 2024-06-20. The firm operates its business in the in vitro diagnostic products business segment. The Company’s main product is antigen test kit that uses immunochromatography to enable rapid diagnosis at the patient's side without the need for special equipment. The products include ImunoAce Flu, ImunoAce SARSCoV-2 II, ImunoAce SARSCoV-2 Saliva, ImunoAce SARSCoV-2/Flu, ImunoAce Adeno, ImunoAce Strep A Neo, ImunoAce hMPV, ImunoAce Mycopiasma, ImunoAce RSV Neo and ImunoAce Noro.

197A Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
34.8%
=
Operating Income
¥5.1B
/
Revenue
¥14.6B
What is Tauns Laboratories Inc's current Operating Margin?

The current Operating Margin for Tauns Laboratories Inc is 34.8%, which is below its 3-year median of 43.4%.

How has Operating Margin changed over time?

Over the last 1 years, Tauns Laboratories Inc’s Operating Margin has decreased from 44.8% to 34.8%. During this period, it reached a low of 34.8% on Oct 30, 2025 and a high of 46.4% on Mar 31, 2025.

Back to Top